Novo won't launch CagriSema in Europe for 'a couple of years,' CFO says

Novo won't launch its big obesity hope CagriSema in Europe for another “couple of years,” Novo’s outgoing CFO Karsten Munk Knudsen told Endpoints News in a Wednesday interview. “For CagriSema, the clear ...